Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12773051rdf:typepubmed:Citationlld:pubmed
pubmed-article:12773051lifeskim:mentionsumls-concept:C0028027lld:lifeskim
pubmed-article:12773051lifeskim:mentionsumls-concept:C1332322lld:lifeskim
pubmed-article:12773051lifeskim:mentionsumls-concept:C2718002lld:lifeskim
pubmed-article:12773051lifeskim:mentionsumls-concept:C1880355lld:lifeskim
pubmed-article:12773051pubmed:issue12lld:pubmed
pubmed-article:12773051pubmed:dateCreated2003-5-29lld:pubmed
pubmed-article:12773051pubmed:abstractTextBy applying a novel cell- and caspase-based HTS assay, a series of N-phenyl nicotinamides has been identified as a new class of potent inducers of apoptosis. Through SAR studies, a 20-fold increase in potency was achieved from a screening hit N-(4-methoxy-2-nitrophenyl)pyridine-3-carboxamide (1) to lead compound 6-methyl-N-(4-ethoxy-2-nitrophenyl)pyridine-3-carboxamide (10), with an EC(50) of 0.082 microM in the caspase activation assay in T47D breast cancer cells. The N-phenyl nicotinamides also were found to be active in the growth inhibition assay where compound 10 had a GI(50) value of 0.21 microM in T47D cells. More importantly, compound 10 was found to be equipotent in MES-SA cells and paclitaxel-resistant, p-glycoprotein overexpressed MES-SA/DX5 cells. Compounds 1 and 6-chloro-N-(4-ethoxy-2-nitrophenyl)pyridine-3-carboxamide (8), a more potent analogue, were found to arrest T47D cells in G(2)/M phase of the cell cycle followed by induction of apoptosis as measured by flow cytometry. Compound 8, which was more potent than 1 in the caspase activation assay, also was found to be more potent in G(2)/M arrest and apoptosis assay. These data confirm that the cell-based caspase activation assay is useful for screening for inducers of apoptosis, as well as for SAR studies and lead optimization. Upon further characterization, N-phenyl nicotinamides were found to be inhibitors of microtubule polymerization in vitro. The identification of N-phenyl nicotinamides as a novel series of inducers of apoptosis demonstrates that our cell- and caspase-based HTS assay is useful for the discovery and optimization of potentially novel anticancer agents.lld:pubmed
pubmed-article:12773051pubmed:languageenglld:pubmed
pubmed-article:12773051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:citationSubsetIMlld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12773051pubmed:statusMEDLINElld:pubmed
pubmed-article:12773051pubmed:monthJunlld:pubmed
pubmed-article:12773051pubmed:issn0022-2623lld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:KasibhatlaSha...lld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:GuastellaJohn...lld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:TsengBenBlld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:DreweJohnJlld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:CaiSui...lld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:NguyenBaoBlld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:JiaShaojuanSlld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:HerichJohnJlld:pubmed
pubmed-article:12773051pubmed:authorpubmed-author:ReddySanjeeva...lld:pubmed
pubmed-article:12773051pubmed:issnTypePrintlld:pubmed
pubmed-article:12773051pubmed:day5lld:pubmed
pubmed-article:12773051pubmed:volume46lld:pubmed
pubmed-article:12773051pubmed:ownerNLMlld:pubmed
pubmed-article:12773051pubmed:authorsCompleteYlld:pubmed
pubmed-article:12773051pubmed:pagination2474-81lld:pubmed
pubmed-article:12773051pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:meshHeadingpubmed-meshheading:12773051...lld:pubmed
pubmed-article:12773051pubmed:year2003lld:pubmed
pubmed-article:12773051pubmed:articleTitleDiscovery of substituted N-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay.lld:pubmed
pubmed-article:12773051pubmed:affiliationCytovia, Inc., 6650 Nancy Ridge Drive, San Diego, California 92121, USA. scai@maxim.comlld:pubmed
pubmed-article:12773051pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12773051lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12773051lld:pubmed